IFM Investors Pty Ltd Has $2.65 Million Stock Position in Align Technology, Inc. $ALGN

IFM Investors Pty Ltd boosted its position in Align Technology, Inc. (NASDAQ:ALGN) by 1.8% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 13,981 shares of the medical equipment provider’s stock after purchasing an additional 251 shares during the period. IFM Investors Pty Ltd’s holdings in Align Technology were worth $2,647,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of ALGN. Compagnie Lombard Odier SCmA acquired a new stake in Align Technology in the 1st quarter valued at about $32,000. Center for Financial Planning Inc. acquired a new stake in Align Technology during the first quarter worth approximately $35,000. SVB Wealth LLC acquired a new stake in Align Technology during the first quarter worth approximately $36,000. Mather Group LLC. lifted its position in Align Technology by 375.0% during the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock worth $69,000 after acquiring an additional 345 shares during the last quarter. Finally, Covestor Ltd lifted its position in Align Technology by 18.8% during the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after acquiring an additional 78 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Stock Down 0.2%

Shares of Align Technology stock opened at $131.18 on Tuesday. Align Technology, Inc. has a twelve month low of $127.70 and a twelve month high of $260.35. The stock has a market cap of $9.51 billion, a price-to-earnings ratio of 22.12, a P/E/G ratio of 1.48 and a beta of 1.65. The company’s fifty day moving average is $152.46 and its 200 day moving average is $168.07.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.06 billion. Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The business’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. As a group, equities analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has approved a share buyback plan on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to buy up to 2% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

Analysts Set New Price Targets

Several brokerages have issued reports on ALGN. Mizuho set a $210.00 price objective on shares of Align Technology in a research report on Thursday, July 31st. Zacks Research downgraded shares of Align Technology from a “hold” rating to a “strong sell” rating in a research report on Monday, September 1st. Morgan Stanley restated an “equal weight” rating and set a $154.00 price objective (down from $249.00) on shares of Align Technology in a research report on Thursday, July 31st. Stifel Nicolaus cut their price objective on shares of Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research report on Thursday, July 31st. Finally, Piper Sandler cut their price objective on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $215.00.

Insider Buying and Selling

In other news, CEO Joseph M. Hogan purchased 7,576 shares of the business’s stock in a transaction on Friday, August 1st. The shares were acquired at an average price of $131.49 per share, with a total value of $996,168.24. Following the completion of the transaction, the chief executive officer owned 184,945 shares of the company’s stock, valued at $24,318,418.05. The trade was a 4.27% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.66% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.